The way pharmaceutical stocks struggled in the second half of 2015, it’s hard to believe they dominated among the year’s best stocks. Consumer demand for cures and treatments was so strong that not even the awful summer and fall were enough to dislodge drug companies as the year’s best stocks. Of the 50 best stocks, as many as 20 were drugmakers.